Otonomy, Inc. OTIC Cash Flow

Otonomy, inc. (OTIC)

CashFlow / Yearly

Dec'19	Dec'18	Dec'17	Dec'16	Dec'15	Dec'14	Dec'13	Dec'12
Cash flows from operating activities:
Net loss
-44,675	-50,368	-90,130	-110,583	-	-	-	-
Net loss
-	-	-	-	-61,668	-42,877	-19,559	-7,569
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
1,149	1,186	1,289	708	358	213	-	-
Depreciation and amortization
-	-	-	-	-	-	257	192
Stock-based compensation
4,890	12,414	13,661	12,611	7,716	1,692	183	191
Non-cash license fee
-	-	-	-	447	0	0	-
Loss on disposal of assets
-	-	-	-	-110	0	0	-
Reserve for excess and obsolete inventory
0	0	1,546	304	0	-	-	-
Accretion of discounts on short-term investments
787	506	-358	-780	-	-	-	-
Non-cash interest expense
-	-	-	-	-	39	2,528	444
Change in fair value of convertible preferred stock warrant liability
-	-	-	-	-	3,300	-2,833	-100
Change in fair value of convertible preferred stock purchase right
-	-	-	-	-	-	-	3,707
Amortization of debt discount
189	0	0	-	13	1	0	0
Impairment of property, plant and equipment
0	0	400	602	0	0	-	-
Deferred rent
0	-103	-2,272	-358	-86	73	24	-317
Changes in operating assets and liabilities:
Accounts receivable, net
-60	1	16	91	0	0	-	-
Inventory
-	-	-	1,739	0	0	-	-
Prepaid and other assets
-476	492	-2,761	613	2,243	34	1,013	530
Accounts payable
127	68	-398	-2,158	1,659	-309	874	641
Accrued expenses
1,656	-166	-5,518	3,866	1,012	2,498	60	-472
Accrued compensation
-42	-672	-1,532	1,650	2,614	331	60	-235
Right-of-use assets and lease liabilities, net
32	0	0	-	-	-	-	-
Net cash used in operating activities
-36,925	-38,434	-75,307	-94,305	-	-	-	-
Cash flows from investing activities:
Net cash used in operating activities
-	-	-	-	-49,896	-35,219	-19,467	-10,828
Purchases of short-term investments
85,004	104,270	129,308	261,242	41,332	16,224	0	0
Maturities of short-term investments
114,000	142,750	199,565	114,371	31,370	0	0	-
Purchases of property and equipment
700	496	1,259	2,546	2,019	782	486	185
Net cash provided by (used in) investing activities
28,296	37,984	68,998	-149,417	-	-	-	-
Cash flows from financing activities:
Proceeds from issuance of long-term debt, net of cash issuance costs
0	14,830	0	0	-	-	-	-
Proceeds from issuance of common stock, net of transaction costs
-	-	-	-	-	-	-	0
Proceeds from exercise of stock options
-	-	-	-	-	-	5	-
Increase in restricted cash
-	-	-	-	-	-75	25	0
Net cash provided by investing activities
-	-	-	-	-11,981	-16,931	-511	-185
Proceeds from convertible notes payable
-	-	-	-	-	-	7,009	8,011
Proceeds from issuance of convertible preferred stock, net of issuance costs
-	-	-	-	-	49,239	45,585	0
Proceeds from issuance of common stock
242	303	448	108,850	80,731	104,126	0	-
Proceeds from exercise of stock options
5	32	622	366	680	110	-	-
Payments of debt issuance costs
52	0	0	-	-	-	-	-
Net cash used in financing activities
195	15,165	1,070	109,216	-	-	-	-
Net change in cash, cash equivalents and restricted cash
-8,434	14,715	-5,239	-134,506	-	-	-	-
Proceeds from issuance of restricted common stock and exercise of stock options, net of early exercise liability
-	-	-	-	-	-	-	3
Proceeds from exercise of common stock warrants
-	-	-	-	-	-	-	0
Net cash provided by financing activities
-	-	-	-	81,426	154,676	52,599	8,014
Net change in cash, cash equivalents and restricted cash
-	-	-	-	19,549	-	-	-
Net change in cash
-	-	-	-	-	102,526	32,621	-2,999
Supplemental cash flow disclosures
Cash paid for interest
1,394	4	0	0	-	-	-	-
Supplemental disclosure of non-cash investing activities:
Purchase of property and equipment in accounts payable and accrued expenses
76	7	132	647	286	5	15	0
Debt issuance costs in accounts payable and accrued expenses
0	66	0	0	-	-	-	-
Debt issuance costs
0	771	0	0	-	-	-	-
Conversion of convertible notes payable and accrued interest into convertible preferred stock
-	-	-	-	-	-	15,982	0
Deferred public offering costs in accounts payable and accrued expenses
-	-	-	-	288	164	0	0